Across TCGA pan-cancer cohorts, RPS29P24 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPS29P24’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where RPS29P24 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS29P24 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA are the cancer types where RPS29P24 tumor–normal differential expression is most reproducible.